Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
35.53
+1.80 (5.34%)
Feb 21, 2025, 4:00 PM EST - Market closed
Moderna Analyst Ratings
Total Analysts
20
Consensus Rating
Hold
Price Target
$59.65
Upside
+67.89%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $96 → $78 | Strong Buy | Maintains | $96 → $78 | +119.53% | Feb 19, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $40 | Hold | Reiterates | $40 | +12.58% | Feb 18, 2025 |
| Barclays | Barclays | Buy → Hold Downgrades $111 → $45 | Buy → Hold | Downgrades | $111 → $45 | +26.65% | Feb 18, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $41 → $34 | Sell | Maintains | $41 → $34 | -4.31% | Feb 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $99 → $51 | Strong Buy → Hold | Downgrades | $99 → $51 | +43.54% | Jan 29, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $112 → $99 | Strong Buy | Maintains | $112 → $99 | +178.64% | Jan 28, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $60 → $50 | Hold | Maintains | $60 → $50 | +40.73% | Jan 27, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $70 → $38 | Hold | Maintains | $70 → $38 | +6.95% | Jan 15, 2025 |
| UBS | UBS | Strong Buy Maintains $108 → $96 | Strong Buy | Maintains | $108 → $96 | +170.19% | Jan 8, 2025 |
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 18, 2024 |
| B of A Securities | B of A Securities | Sell Initiates $41 | Sell | Initiates | $41 | +15.40% | Dec 10, 2024 |
| JP Morgan | JP Morgan | Sell Maintains $59 → $45 | Sell | Maintains | $59 → $45 | +26.65% | Nov 26, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $115 → $69 | Buy | Reiterates | $115 → $69 | +94.20% | Nov 18, 2024 |
| HSBC | HSBC | Hold → Strong Buy Upgrades $58 | Hold → Strong Buy | Upgrades | $58 | +63.24% | Nov 18, 2024 |
| Wolfe Research | Wolfe Research | Sell Initiates $40 | Sell | Initiates | $40 | +12.58% | Nov 15, 2024 |
| Barclays | Barclays | Buy Maintains $125 → $111 | Buy | Maintains | $125 → $111 | +212.41% | Nov 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.